Indacaterol / Glycopyrronium
- MDIIndacaterol / GlycopyrroniumUltibro Breezhaler
Mechanism of Action
- Contains a long acting muscarinic agent (LAMA) as well as a long-acting beta 2 agonist (LABA), both of which are bronchodilators.
Clinical Use
Indications
- Maintenance therapy for COPD.
- Adverse Effects
- Tremor
- Palpitations
- Headache
- Dry Mouth